Works matching DE "HER2 gene"

Results: 910

Parental loss at age birth to 21 years and daughters' breast cancer and tumor characteristics.

Published in:

JNCI Cancer Spectrum, 2025, v. 9, n. 2, p. 1, doi. 10.1093/jncics/pkaf004

By:

Keeler, Corinna;
Krigbaum, Nickilou Y;
Cohn, Barbara;
Cirillo, Piera

Publication type:

Article

Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.

Published in:

Modern Pathology, 2004, v. 17, n. 10, p. 1235, doi. 10.1038/modpathol.3800171

By:

Saad, Reda S.;
Yulin Liu;
Han, Helen;
Landreneau, Rodney J.;
Silverman, Jan F.

Publication type:

Article

Immunological low-dose radiation modulates the pediatric medulloblastoma antigens and enhances antibody-dependent cellular cytotoxicity.

Published in:

Child's Nervous System, 2017, v. 33, n. 3, p. 429, doi. 10.1007/s00381-016-3305-x

By:

Das, Arabinda;
McDonald, Daniel;
Lowe, Stephen;
Bredlau, Amy-Lee;
Vanek, Kenneth;
Patel, Sunil;
Cheshier, Samuel;
Eskandari, Ramin

Publication type:

Article

Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 361, doi. 10.1007/s00280-005-1026-z

By:

Bruno, Rene;
Washington, Carla B.;
Jian-Feng Lu;
Lieberman, Grazyna;
Banken, Ludger;
Klein, Pamela

Publication type:

Article

Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer.

Published in:

Amino Acids, 2016, v. 48, n. 2, p. 487, doi. 10.1007/s00726-015-2102-2

By:

Meng, Xuli;
Li, Yongfeng;
Tang, Hongchao;
Mao, Weimin;
Yang, Hongjian;
Wang, Xiaojia;
Ding, Xianfeng;
Xie, Shangnao

Publication type:

Article

Targeted HER2 Treatment in Advanced Gastric Cancer.

Published in:

Oncology, 2010, v. 78, n. 1, p. 26, doi. 10.1159/000288295

By:

Jørgensen, Jan Trøst

Publication type:

Article

Current Status of HER2 Testing.

Published in:

Oncology, 2002, v. 63, p. 25, doi. 10.1159/000066204

By:

Di Leo, Angelo;
Dowsett, Mitch;
Horten, Bruce;
Penault-Llorca, Frédérique

Publication type:

Article

Emerging Technologies for HER2 Testing.

Published in:

Oncology, 2002, v. 63, p. 33, doi. 10.1159/000066199

By:

van de Vijver, Marc

Publication type:

Article

Title Page / Contents / Preface.

Published in:

Oncology, 2001, v. 61, p. I, doi. 10.1159/000055395

By:

Khayat, David

Publication type:

Article

Biology of HER2 and Its Importance in Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 1, doi. 10.1159/000055396

By:

Yarden, Yosef

Publication type:

Article

Testing for HER2 Status.

Published in:

Oncology, 2001, v. 61, p. 22, doi. 10.1159/000055398

By:

Hanna, Wedad

Publication type:

Article

First-Line Herceptin[sup ®] Monotherapy in Metastatic Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 37, doi. 10.1159/000055400

By:

Vogel, Charles L.;
Cobleigh, Melody A.;
Tripathy, Debu;
Gutheil, John C.;
Harris, Lyndsay N.;
Fehrenbacher, Louis;
Slamon, Dennis J.;
Murphy, Maureen;
Novotny, William F.;
Burchmore, Michael;
Shak, Steven;
Stewart, Stanford J.

Publication type:

Article

Interaction between Herceptin[sup ®] and Taxanes.

Published in:

Oncology, 2001, v. 61, p. 43, doi. 10.1159/000055401

By:

Diéras, Véronique;
Beuzeboc;
Laurence;
Pierga;
Pouillart

Publication type:

Article

New Combinations with Herceptin[sup ®] in Metastatic Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 50, doi. 10.1159/000055402

By:

Winer, Eric P.;
Burstein, Harold J.

Publication type:

Article

HER2 as a Prognostic Factor in Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 67, doi. 10.1159/000055404

By:

Ménard, Sylvie;
Fortis, Stefania;
Castiglioni, Fabio;
Agresti, Roberto;
Balsari, Andrea

Publication type:

Article

The Predictive Value of HER2 in Breast Cancer.

Published in:

Oncology, 2001, v. 61, p. 73, doi. 10.1159/000055405

By:

Piccart, Martine;
Lohrisch, Caroline;
Di Leo, Angelo;
Larsimont, Denis

Publication type:

Article

Role of Herceptin[sup ®] in Primary Breast Cancer: Views from North America and Europe.

Published in:

Oncology, 2001, v. 61, p. 83, doi. 10.1159/000055406

By:

Leyland-Jones, Brian;
Smith, Ian

Publication type:

Article

Vitamin D Receptor Gene BsmI Polymorphism Correlates with erbB-2/HER-2 Expression in Human Rectal Cancer.

Published in:

Oncology, 2000, v. 58, n. 3, p. 242, doi. 10.1159/000012107

By:

Speer;
Dworak;
Cseh;
Bori;
Salamon;
Török;
Winkler;
Vargha;
Nagy;
Takács;
Kucsera;
Lakatos

Publication type:

Article

Role of Estrogen and Estrogen-Related Growth Factor in the Mechanism of Hormone Dependency of Endometrial Carcinoma Cells.

Published in:

Oncology, 1998, v. 55, p. 35, doi. 10.1159/000055257

By:

Hata, Hiroki;
Hamano, Mieko;
Watanabe, Jun;
Kuramoto, Hiroyuki

Publication type:

Article

Impact of Low HER2 Expression on Neoadjuvant Treatment Response in Early Luminal Breast Cancer.

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 8, p. 4355, doi. 10.21608/zumj.2024.313346.3524

By:

Mohamed, Amrallah A.;
Elfaragy, Ola M.;
Erfan Abdelwahab, Fatma Mohamed;
Abdelrahman, Aziza E.

Publication type:

Article

Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer.

Published in:

Turkish Journal of Medical Sciences, 2017, v. 47, n. 6, p. 1791, doi. 10.3906/sag-1702-152

By:

KOMBAK, Faruk Erdem;
ŞAHİN, Hülya;
MOLLAMEMİŞOĞLU, Hande;
ÖNEM, İdris;
KAYA, Handan;
BUĞDAYCI, Onur;
ARIBAL, Erkin

Publication type:

Article

Problem-solving Test: Real-time Polymerase Chain Reaction.

Published in:

Biochemistry & Molecular Biology Education, 2009, v. 37, n. 4, p. 250

By:

Szeberényi, József

Publication type:

Article

HER2 genotype and tumor cells proliferation in urinary bladder cancer.

Published in:

Oncolog-Hematolog, 2024, n. 67, p. 49

By:

Dumitru, Mirela;
Mihăilă, Mirela;
Hotnog, Camelia-Mia;
Botezatu, Anca;
Vasilescu, Monica-Maria;
Panait, Marieta-Elena;
Hortopan, Monica;
Anton, Gabriela;
Braşoveanu, Lorelei-Irina

Publication type:

Article

A comparison study of HER2 protein overexpression and its gene status in breast cancer.

Published in:

Malaysian Journal of Pathology, 2019, v. 41, n. 2, p. 133

By:

MD PAUZI, Suria Hayati;
SAARI, Hanis Nabihah;
ROSLAN, Muhammad Ridzuan;
SYED KHAIR AZMAN JAMALULIL, Sharifah Nor Shairah;
TAUAN, Irene Scully;
MOHD RUSLI, Fatin Adiela;
AIZUDDIN, Azimatun Noor

Publication type:

Article

Unraveling the Complexities of Targeted Therapy Treatment in Cancer Care.

Published in:: ONS News, 2004, v. 19, p. 73
Publication type:: Article

Functional analysis of a putative HER2-associated expressed enhancer, Her2-Enhancer1, in breast cancer cells.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46460-x

By:

Rojhannezhad, Mahdieh;
Soltani, Bahram M.;
Vasei, Mohammad;
Ghorbanmehr, Nassim;
Mowla, Seyed Javad

Publication type:

Article

Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization images.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36811-z

By:

Xue, Tian;
Chang, Heng;
Ren, Min;
Wang, Haochen;
Yang, Yu;
Wang, Boyang;
Lv, Lei;
Tang, Licheng;
Fu, Chicheng;
Fang, Qu;
He, Chuan;
Zhu, Xiaoli;
Zhou, Xiaoyan;
Bai, Qianming

Publication type:

Article

Breast biomarkers evolution between primary and distant metastasis: incidence and significance.

Published in:

Histopathology, 2025, v. 86, n. 5, p. 793, doi. 10.1111/his.15387

By:

Khedr, Maha;
Gandhi, Shipra;
Roy, Arya Mariam;
Alharbi, Malak;
George, Anthony;
Attwood, Kristopher;
Khoury, Thaer

Publication type:

Article

Digital image analysis and assisted reading of the HER2 score display reduced concordance: pitfalls in the categorisation of HER2‐low breast cancer.

Published in:

Histopathology, 2023, v. 82, n. 6, p. 912, doi. 10.1111/his.14877

By:

Sode, Michael;
Thagaard, Jeppe;
Eriksen, Jens Ole;
Laenkholm, Anne‐Vibeke

Publication type:

Article

Refining the definition of HER2‐low class in invasive breast cancer.

Published in:

Histopathology, 2022, v. 81, n. 6, p. 770, doi. 10.1111/his.14780

By:

Atallah, Nehal M;
Toss, Michael S;
Green, Andrew R;
Mongan, Nigel P;
Ball, Graham;
Rakha, Emad A

Publication type:

Article

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer.

Published in:

Histopathology, 2022, v. 81, n. 4, p. 511, doi. 10.1111/his.14728

By:

Katayama, Ayaka;
Starczynski, Jane;
Toss, Michael S;
Shaaban, Abeer M;
Provenzano, Elena;
Quinn, Cecily M;
Callagy, Grace;
Purdie, Colin A;
Millican‐Slater, Rebecca;
Purnell, David;
Chagla, Leena;
Oyama, Tetsunari;
Pinder, Sarah E;
Chan, Steve;
Ellis, Ian;
Lee, Andrew H S;
Rakha, Emad A

Publication type:

Article

Upper GI biopsies for adenocarcinoma – how many biopsies should endoscopists take?

Published in:

Histopathology, 2019, v. 74, n. 6, p. 959, doi. 10.1111/his.13816

By:

Kaye, Philip;
Lindsay, Daniel;
Madhusudan, Srinivasan;
Vohra, Ravinder;
Catton, James;
Platt, Craig;
Ragunath, Krish

Publication type:

Article

Digital image analysis of HER2 immunohistochemistry in gastric- and oesophageal adenocarcinoma: a validation study on biopsies and surgical specimens.

Published in:

Histopathology, 2018, v. 72, n. 1, p. 191, doi. 10.1111/his.13322

By:

Koopman, Timco;
Buikema, Henk J;
Vegt, Bert;
Bock, Geertruida H;
Smits, Maria M;
Louwen, Maarten;
Hage, Mariska;
Imholz, Alex L T

Publication type:

Article

Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer.

Published in:

Histopathology, 2017, v. 70, n. 4, p. 622, doi. 10.1111/his.13108

By:

Rakha, Emad A;
Agarwal, Devika;
Green, Andrew R;
Ashankyty, Ibraheem;
Ellis, Ian O;
Ball, Graham;
Alaskandarany, Mohammed A

Publication type:

Article

The FlexISH assay brings flexibility to cytogenetic HER2 testing.

Published in:

Histopathology, 2016, v. 69, n. 4, p. 635, doi. 10.1111/his.12974

By:

Brockhoff, Gero;
Bock, Maria;
Zeman, Florian;
Hauke, Sven

Publication type:

Article

Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates.

Published in:

Histopathology, 2016, v. 68, n. 3, p. 356, doi. 10.1111/his.12763

By:

Kamata, Tsugumasa;
Yoshida, Akihiko;
Shiraishi, Kouya;
Furuta, Koh;
Kosuge, Tomoo;
Watanabe, Shun‐ichi;
Asamura, Hisao;
Tsuta, Koji

Publication type:

Article

Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA.

Published in:

Cellular Microbiology, 2009, v. 11, n. 3, p. 488, doi. 10.1111/j.1462-5822.2008.01269.x

By:

Tegtmeyer, Nicole;
Zabler, Dana;
Schmidt, Diana;
Hartig, Roland;
Brandt, Sabine;
Backert, Steffen

Publication type:

Article

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?

Published in:

Case Reports in Gastrointestinal Medicine, 2015, v. 2015, p. 1, doi. 10.1155/2015/132030

By:

Ishimine, Yu;
Goto, Akira;
Watanabe, Yoshito;
Yajima, Hidetaka;
Nakagaki, Suguru;
Yabana, Takashi;
Adachi, Takeya;
Kondo, Yoshihiro;
Kasai, Kiyoshi

Publication type:

Article

Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.

Published in:

Oncogene, 2015, v. 34, n. 26, p. 3413, doi. 10.1038/onc.2014.272

By:

Cordo Russo, R I;
Béguelin, W;
Díaz Flaqué, M C;
Proietti, C J;
Venturutti, L;
Galigniana, N;
Tkach, M;
Guzmán, P;
Roa, J C;
O'Brien, N A;
Charreau, E H;
Schillaci, R;
Elizalde, P V

Publication type:

Article

A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation.

Published in:

Oncogene, 2015, v. 34, n. 17, p. 2215, doi. 10.1038/onc.2014.167

By:

Yan, Y;
Hein, A L;
Greer, P M;
Wang, Z;
Kolb, R H;
Batra, S K;
Cowan, K H

Publication type:

Article

PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling.

Published in:

Oncogene, 2015, v. 34, n. 16, p. 2061, doi. 10.1038/onc.2014.153

By:

Moody, S E;
Schinzel, A C;
Singh, S;
Izzo, F;
Strickland, M R;
Luo, L;
Thomas, S R;
Boehm, J S;
Kim, S Y;
Wang, Z C;
Hahn, W C

Publication type:

Article

Heterogeneity in ERK activity as visualized by in vivo FRET imaging of mammary tumor cells developed in MMTV-Neu mice.

Published in:

Oncogene, 2015, v. 34, n. 8, p. 1051, doi. 10.1038/onc.2014.28

By:

Kumagai, Y;
Naoki, H;
Nakasyo, E;
Kamioka, Y;
Kiyokawa, E;
Matsuda, M

Publication type:

Article

HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors.

Published in:

Oncogene, 2015, v. 34, n. 2, p. 217, doi. 10.1038/onc.2013.540

By:

Andrechek, E R

Publication type:

Article

Clinical Features of Male Breast Cancer: Experiences from Seven Institutions Over 20 Years.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1389, doi. 10.4143/crt.2015.410

By:

Ji Hyung Hong;
Kyung Sun Ha;
Yun Hwa Jung;
Hye Sung Won;
Ho Jung An;
Guk Jin Lee;
Donghoon Kang;
Ji Chan Park;
Sarah Park;
Jae Ho Byun;
Young Jin Suh;
Jeong Soo Kim;
Woo Chan Park;
Sang Seol Jung;
Il Young Park;
Su-Mi Chung;
In Sook Woo

Publication type:

Article

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1373, doi. 10.4143/crt.2015.475

By:

Se Hyun Kim;
Kyung Hae Jung;
Tae-Yong Kim;
Seock-Ah Im;
In Sil Choi;
Yee Soo Chae;
Sun Kyung Baek;
Seok Yun Kang;
Sarah Park;
In Hae Park;
Keun Seok Lee;
Yoon Ji Choi;
Soohyeon Lee;
Joo Hyuk Sohn;
Yeon-Hee Park;
Young-Hyuck Im;
Jin-Hee Ahn;
Sung-Bae Kim;
Jee Hyun Kim

Publication type:

Article

Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1363, doi. 10.4143/crt.2015.456

By:

Eunjin Jwa;
Kyung Hwan Shin;
Ja Young Kim;
Young Hee Park;
So-Youn Jung;
Eun Sook Lee;
In Hae Park;
Keun Seok Lee;
Jungsil Ro;
Yeon-Joo Kim;
Tae Hyun Kim

Publication type:

Article

Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node-Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1351, doi. 10.4143/crt.2015.444

By:

Guiyun Sohn;
Sei Hyun Ahn;
Hee Jeong Kim;
Byung-Ho Son;
Jong Won Lee;
Beom Seok Ko;
Yura Lee;
Sae Byul Lee;
Seunghee Baek

Publication type:

Article

Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms.

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 2, p. 715, doi. 10.4143/crt.2015.227

By:

Jinho Kang;
Joo Hee Park;
Hye Jin Lee;
Ukhyun Jo;
Jong Kuk Park;
Jae Hong Seo;
Yeul Hong Kim;
Insun Kim;
Kyong Hwa Park

Publication type:

Article

IMPORTANCE OF COPY NUMBER ALTERATIONS OF FGFR1 AND C-MYC GENES IN TRIPLE NEGATIVE BREAST CANCER.

Published in:

Journal of Medical Biochemistry, 2019, v. 38, n. 1, p. 63, doi. 10.2478/jomb-2018-0012

By:

Nedeljković, Milica;
Tanić, Nikola;
Dramićanin, Tatjana;
Milovanović, Zorka;
Šušnjar, Snežna;
Milinković, Vedrana;
Vujović, Ivana;
Prvanović, Mirjana;
Tanić, Nasta

Publication type:

Article

Closing the Evidence Gap in the Use of Emerging Testing Technologies in Clinical Practice.

Published in:

JAMA: Journal of the American Medical Association, 2008, v. 300, n. 21, p. 2542, doi. 10.1001/jama.2008.754

By:

Phillips, Kathryn A.

Publication type:

Article